Abbott shares slide after trial verdict, weigh on rival Reckitt Benckiser
(Reuters) -Abbott Laboratories’ shares fell nearly 7% premarket, while British peer Reckitt Benckiser slumped 9% on Monday, after the U.S.…
(Reuters) -Abbott Laboratories’ shares fell nearly 7% premarket, while British peer Reckitt Benckiser slumped 9% on Monday, after the U.S.…
(Reuters) – Tesla shares jumped nearly 6% on Monday after Morgan Stanley named the most valuable automaker its “top pick”…
By Savyata Mishra (Reuters) -McDonald’s reported a surprise drop in sales worldwide on Monday, its first decline in 13 quarters,…
(Reuters) -Natural gas producer Chesapeake Energy on Monday reported a second-quarter loss, compared to a year-ago profit, dented by persistently…
By Michael Erman (Reuters) -Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth from new products like anemia…
MEXICO CITY (Reuters) -Alleged Mexican kingpin Ismael “El Mayo” Zambada has pleaded not guilty to U.S. drug trafficking charges, court…
By Allison Lampert and David Shepardson WASHINGTON (Reuters) -Boeing is asking suppliers to disclose records on Chinese titanium since 2014,…
By Sheila Dang (Reuters) – The Paris Olympics will be a showcase of generative AI for American viewers but European…
By Kenrick Cai Alphabet’s Google unveiled a pair of artificial intelligence systems on Thursday that demonstrated advances in solving complex…
(Reuters) – L3Harris raised its outlook for 2024 after beating Wall Street estimates for second-quarter profit on Thursday, betting on…